Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE

Novatek requalified as a supplier for Boehringer Ingelheim’s aseptic manufacturing facilities

By Brian Buntz | May 26, 2021

NovatekEnvironmental monitoring software developer Novatek (Quebec, Canada) has extended its partnership with Boehringer Ingelheim. In particular, Novatek has announced that it has won reapproval from the drugmaker to use its software in its human pharma, animal health and biopharmaceutical aseptic (sterile) manufacturing sites internationally.

“We are excited to announce that Novatek is requalified as an approved supplier of Boehringer Ingelheim for Novatek’s Environmental Monitoring Software around the world,” said Mazda Famili, vice president quality at Novatek International, in a statement. 

Ingelheim, Germany–headquartered Boehringer Ingelheim is the world’s largest private pharma company.

Boehringer Ingelheim selected Novatek as an approved vendor and partner in 2017. 

Novatek’s software supports the management of multiple critical aspects within quality-controlled environments. Novatek’s environmental monitoring management software supports labeling, collection and tracking of environmental monitoring samples in cleanroom environments. 

Novatek also has supported Dr. Reddy’s Laboratories, Zoetis, Medtronic and Pfizer. 

About The Author

Brian Buntz

The pharma and biotech editor of WTWH Media, Brian is a veteran journalist with more than 15 years of experience covering an array of life science topics, including clinical trials, drug discovery and development and medical devices. Before coming to WTWH, he served as content director focused on connected devices at Informa. In addition, Brian covered the medical device sector for 10 years at UBM. At Qmed, he overhauled the brand’s news coverage and helped to grow the site’s traffic volume dramatically. He had previously held managing editor roles on two of the company’s medical device technology publications. Connect with him on LinkedIn or email at [email protected].

Tell Us What You Think! Cancel reply

Related Articles Read More >

This is the logo of Novartis.
Novartis breaks ground on North Carolina facility
Eli Lilly Huntsville Alabama Facility rendering (1)
Eli Lilly to build new $6B API manufacturing facility in Alabama
Thermo Fisher Scientific
Thermo Fisher expands investment in Asia bioprocessing for biopharma production
AstraZeneca
AstraZeneca to invest $2B in Maryland, support 2,600 jobs
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE